1. T-cell acute lymphoblastic leukemia;Raetz EA;Hematology Am Soc Hematol Educ Program. 2016 Dec
2. T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993);Marks DI;Blood,2009
3. Children’s Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia;Dunsmore KP;JCO,2020
4. Rowntree CJ, Kirkwood AA, Clifton-Hadley L, Farah N, Mansour MR, Hussain J, et al. First Analysis of the UKALL14 Randomized Trial to Determine Whether the Addition of Nelarabine to Standard Chemotherapy Improves Event Free Survival in Adults with T-Cell Acute Lymphoblastic Leukaemia (CRUK/09/006). Blood. 2021 Nov 5;138(Supplement 1):366.
5. Ko RH, Ji L, Barnette P, Bostrom B, Hutchinson R, Raetz E, et al. Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study. JCO. 2010 Feb 1;28(4):648–54.